Article
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
21 Sept 2018
Abstract excerpt
To evaluate the potential of an integrated clinical test to detect diverse classes of somatic and germline mutations relevant to pediatric oncology, we performed three-platform whole-genome (WGS), whole exome (WES) and transcriptome (RNA-Seq) sequencing of tumors and normal tissue from 78 pediatric cancer patients in a CLIA-certified, CAP-accredited laboratory. Our analysis pipeline achieves high accuracy by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
